Poland· PL-100211248
Verrumal
A medicinal product containing acidum salicylicum + fluorouracilum, registered in Poland by Almirall Hermal GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Acidum salicylicum + Fluorouracilum
- Manufacturer
- Almirall Hermal GmbH
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990667413
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acidum salicylicum + fluorouracilum in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyActikerallAlmirall Hermal Gmbh
- CzechiaACTIKERALLAlmirall Hermal GmbH, Reinbek
- NorwayActikerallAlmirall Hermal GmbH
- SpainACTIKERALL 5 MG/G + 100 MG/G SOLUCION CUTANEAAlmirall Hermal Gmbh
- SwitzerlandActikerall
- SwedenActikerall 5 mg/g + 100 mg/g Kutan lösningAlmirall Hermal GmbH
- FinlandActikerallAlmirall Hermal GmbH
- United KingdomActikerall 5mg/g / 100mg/g cutaneous solutionAlmirall Ltd
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Actikerall, Verrumal
- Czechia · Actikerall, Verrumal
- Germany · Actikerall, Verrucutan
- Denmark · Actikerall
- Estonia · Actikerall
- Spain · Actikerall, Verrucutan
- Finland · Actikerall
- United Kingdom (Northern Ireland) · Actikerall
- Greece · Actiker, Verruca Hermal
- Croatia · Verrucutan
- Hungary · Verrumal
- Iceland · Actikerall
- Italy · Actikerall
- Luxembourg · Actikerall, Verrumal
- Latvia · Actikerall
- Norway · Actikerall
- Portugal · Actikerall, Verrucare
- Sweden · Actikerall
- Slovakia · Actikerall, Verrumal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e69f93bf-9c4b-4339-b621-b6a1b945f417 GET /v1/drugs/e69f93bf-9c4b-4339-b621-b6a1b945f417?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn do stosowania na skórę",
"source": "urpl",
"strength": "(100 mg + 5 mg)/g",
"packaging": "05909990667413 ¦ Rp ¦ 10577\n1 op. 13 ml",
"substance": "Acidum salicylicum 100 mg/g + Fluorouracilum 5 mg/g",
"common_name": "Acidum salicylicum + Fluorouracilum",
"pl_product_id": "100211248",
"pozwolenie_nr": "06674",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about acidum salicylicum + fluorouracilum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.